[PDF] Top 20 CD30: receptor, marker, target

... a tumor with a small potential for metastasis, its nature is still not well defined. As indicated from its name, it con- sists of numerous myofibroblasts along with inflammatory cells. CD30 expression, if present, ... See full document

... higher receptor expression in tumors than in normal liver ...[5], receptor expression of the metastases can ...of receptor expression on progression-free or overall ... See full document

... chemokine receptor type 4 (CXCR4) has gained tremendous attention over the last decade, since it was found to be upregulated in a wide variety of cancer types, including hepatocellular carcinoma ... See full document

... Renal cell carcinoma: AR expression has been demonstrated in 14.2% (3/21), 14.8% (27/182) and 42% (5/12) of renal cell carcinomas [S45-S47]. AR positivity was associated with a significantly better progression- free ... See full document

... factor receptor super family (20). After stimulation, CD30 employs pleiotropic actions on cell survival and growth, which mainly depend on the NF-κB pathway activation (Buchan and Al-Shamkhani, ...both ... See full document

... new target for obesity and its related dis- eases, like T2DM, and NAFLD, although different re- search groups have reported conflicting ...irisin receptor, the molecular pathways regu- lating irisin, and ... See full document

... Cholangiocarcinoma (CCA) is characterized by a uniquely aggressive behavior and lack of effective targeted therapies. After analyzing the gene expression profiles of seven paired intrahepatic CCA microarrays, a novel ... See full document

... express CD30. They release this receptor on extracellular vesicles (EVs) for the tumor-supporting communication with CD30 ligand (CD30L)-positive bystander ...how CD30-positive EVs influence ... See full document

... Wnt target genes such as MYC, CD44, cyclin D1, Twist1, tyrosine hydroxylase (TH), and the neural stem cell marker ...non-Wnt target genes and stem cells markers Oct4, Sox1, Sox2 and DHH was either ... See full document

... of CD30.CAR-Ts in the absence of circulating target cells may require homeostatic cytokines like IL-15 that will be more available following lympho- depletion ... See full document

... The receptor for the cardiac hormone atrial natriuretic peptide (ANP), natriuretic peptide receptor A (NPR-A), has been reported to be expressed in lung cancer, prostate cancer and ovarian ...new ... See full document

... (cHL), CD30+ non-Hodgkin B cell lympho- mas and very rare ALK-1 positive (and eventually CD30- negative) large B cell ...of CD30 expression is critical and the t(2;5) translocation cannot be ... See full document

... Obesity has become major worldwide health problems. Serotonin (5-hydroxytryptamine; 5-HT) is a neurotransmitter that contributes to the regulation of many physiological processes and abnormalities of the serotonergic ... See full document

... Disclosed herein are genetic markers for pig leanness, methods for identifying such markers, and methods of screening pigs to determine those more or less likely to be obese and more or less likely to produce litters ... See full document

... The location of the receptor-binding region has implications for the structure and presentation of CdiA on the inhibitor cell surface. CdiA effectors are thought to be structurally similar to the FhaB adhesins of ... See full document

... competition for transcriptional coactivators, the body of evidence suggests that inhibition of the NF-κB pathway is involved. Inhibition of this pathway does not entail inhibition of NF-κB translocation to the nucleus, ... See full document

... 56. Eagon PK, Elm MS, Tadic SD, Nanji AA. Downregulation of nuclear sex steroid receptor activity correlates with severity of alcoholic liver injury. Am J Physiol Gastrointest Liver Physiol. ... See full document

... exact role of Notch-1 protein expression remains unclear in human colorectal cancer tumorigenesis. In the present study, we found that the Notch-1 protein was overexpressed in colorectal adenocarcinoma as compared to ... See full document

... for CD30 (range 45–78 %). High numbers of CD4 ? CD30 ? cells were also found in the skin of systemic sclerosis patients (59–87 %), whereas these cells were rare ( \ 10 %) in the skin of con- tact dermatitis ... See full document

... Toll-like receptor 1 TLR2 Toll-like receptor 2 TLR3 Toll-like receptor 3 TLR4 Toll-like receptor 4 TLR5 Toll-like receptor 5 TLR6 Toll-like receptor 6 TLR7 Toll-like ... See full document